Globus Medical, Inc.
GMED
$76.64
-$0.57-0.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.49% | 16.65% | 11.75% | 17.43% | 32.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.49% | 16.65% | 11.75% | 17.43% | 32.26% |
| Cost of Revenue | 3.78% | 0.49% | -3.30% | 16.17% | 53.81% |
| Gross Profit | 35.33% | 26.18% | 20.80% | 18.13% | 21.99% |
| SG&A Expenses | 22.11% | 16.13% | 11.73% | 17.27% | 27.17% |
| Depreciation & Amortization | 0.35% | -0.99% | 0.99% | 17.49% | 55.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.11% | 6.68% | 2.17% | 13.54% | 34.72% |
| Operating Income | 96.98% | 83.63% | 86.94% | 44.79% | 18.30% |
| Income Before Tax | 182.67% | 401.21% | 280.43% | 461.28% | 148.76% |
| Income Tax Expenses | 51.45% | 278.85% | 24.33% | -34.73% | 75.38% |
| Earnings from Continuing Operations | 216.18% | 422.28% | 363.08% | 776.83% | 178.51% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 216.18% | 422.28% | 363.08% | 776.83% | 178.51% |
| EBIT | 96.98% | 83.63% | 86.94% | 44.79% | 18.30% |
| EBITDA | 57.21% | 51.07% | 48.48% | 33.10% | 28.66% |
| EPS Basic | 219.13% | 425.13% | 364.81% | 775.77% | 112.87% |
| Normalized Basic EPS | 115.13% | 117.22% | 75.72% | 34.28% | -4.87% |
| EPS Diluted | 220.16% | 425.84% | 368.77% | 796.24% | 112.66% |
| Normalized Diluted EPS | 116.39% | 117.34% | 75.01% | 33.16% | -5.80% |
| Average Basic Shares Outstanding | -0.88% | -0.37% | -0.16% | 4.28% | 11.73% |
| Average Diluted Shares Outstanding | -1.42% | -0.34% | 0.36% | 5.21% | 12.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |